Mark J. Bluth

Radiology
650 Commack Rd
Commack, NY 11725

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Moesin: A novel receptor on NK lymphocytes binds to TOMM40 on K562 leukemia cells initiating cytolysis.

Moesin: A novel receptor on NK lymphocytes binds to TOMM40 on K562 leukemia cells initiating cytolysis.

Journal: Human immunology
Published: November 19, 2021

Molecular Pathology Techniques: Advances in 2018.

Molecular Pathology Techniques: Advances in 2018.

Journal: Clinics in laboratory medicine
Published: May 20, 2018

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 01, 2018

Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.

Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanoma.

Journal: Melanoma research
Published: October 30, 2016

Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab.

Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 28, 2016

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.

Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial.

Journal: JAMA
Published: June 19, 2014

Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies.

Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies.

Journal: Cancer discovery
Published: March 05, 2014

Molecular pathology techniques.

Molecular pathology techniques.

Journal: Clinics in laboratory medicine
Published: November 26, 2013

Ipilimumab for patients with advanced mucosal melanoma.

Ipilimumab for patients with advanced mucosal melanoma.

Journal: The oncologist
Published: May 30, 2013

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Journal: Cancer
Published: April 22, 2013

Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.

Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.

Journal: The Journal of investigative dermatology
Published: March 10, 2012

Ruptured dermoid cyst arising from Meckel cave.

Ruptured dermoid cyst arising from Meckel cave.

Journal: Neurology. Clinical practice
Published: March 01, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026